Last reviewed · How we verify

NCT06575023

Tamponade vs Partial Myometrial Resection of Lower Uterine Segment in Management of Placenta Accreta Spectrum Cases

Not yet recruiting NA Last updated 28 August 2024
What this trial tests

NA trial testing Tamponade of lower uterine segment in management of placenta accreta spectrum cases in Placenta Accreta in 222 participants. Not yet recruiting.

Timeline
1 September 2024
Primary endpoint
30 August 2026
30 August 2027

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment222
Start date1 September 2024
Primary completion30 August 2026
Estimated completion30 August 2027

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, female only, with Placenta Accreta. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the efficacy of lower uterine tamponade and partial lower myometrial resection in the management of intraoperative bleeding in cases with placenta accreta spectrum .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Placenta Accreta

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06575023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing